Zoey W. Johnson

Protocol Design | Zero-Knowledge Research | Scaling Ethereum's Core

[Zoey W. Johnson @EdavisJero40186]

But trials aren't the finish line. My 3-step map:
1. Lab: target ID
2. Phases I-III: safety then efficacy
3. Approval and post-market watch
That last step never really ends.

[Budget Customer Service @BudgetSPDesk]

big room energy. two paths: if that room funds trials, rails hold; if not, it's just panels. trigger is who follows up next week. keep building.

[Zoey W. Johnson @EdavisJero40186]

Patience isn't passive. It's the trade.

Chasing every candle is how accounts die. I wait for my level or I do nothing. Boring? Good. Boredom beats liquidation.

Still flat. Still fine.

[Zoey W. Johnson @EdavisJero40186]

near-term: another platform pitch. long-term: maybe the actual plumbin healthcare never built.

[LIFE AI @LifeNetwork_AI]

What kind of operational infrastructure does coordination across the healthcare value chain actually require?

Eight years of building clinical programs across Southeast Asia, working with governments, hospital networks, and pharmaceutical companies, produced one consistent finding: the challenge is not the absence of capable AI. It is the absence of operational infrastructure that makes coordination reusable across programs.

Without that infrastructure, coordination remains highly program-specific, especially in drug development, where multiple key players must work together across the development process.

The infrastructure this requires has three properties.

It has to be reusable. Clinical programs should move from bespoke projects to reusable rails, with shared coordination rails replacing bespoke integration at every site.

It has to compound. Every application should strengthen the model, the network, and the protocol, building greater capacity across the ecosystem over time.

It has to enable coordination among independent actors. Hospitals, doctors, labs, pharma sponsors, regulators, patients, and AI builders can contribute services, validation, and clinical execution without surrendering operational sovereignty.

At Life AI, we are building an operating infrastructure for drug development around these requirements, bringing together AI-driven discovery, wet-lab screening, and clinical validation.

[Olivia Lewis @LewisOlivi82505]

$90 spikes yields now, but history shows supply shocks fade fast watch demand data, not headlines, for the real driver.

[Zoey W. Johnson @EdavisJero40186]

@btc
[email protected]

[Zoey W. Johnson @EdavisJero40186]

@btc [email protected]

[Zoey W. Johnson @EdavisJero40186]

I just inscribed my message on the Quip Network Genesis Block! Join the quantum revolution: https://t.co/9vXqotpaWm https://t.co/FLXCepoWki

[Quip Network @quipnetwork]

New quest live: Make quantum history and inscribe your message on the Quip Network genesis block.

> Leave Your Mark

https://t.co/0GC9VP5xGR